These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 26293796)

  • 21. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R; Robinson S; Sheridan T; Mauch PM
    Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective proliferation of lymphoid cells from lineage-c-Kit+ Sca-1+ cells by a clonal bone marrow stromal cell line.
    Koguma M; Matsuda K; Okuyama R; Yanai N; Obinata M
    Exp Hematol; 1998 Apr; 26(4):280-7. PubMed ID: 9546310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of T, B, and myeloid lineage-committed as well as multipotent hemopoietic progenitors in the aorta-gonad-mesonephros region of day 10 fetuses of the mouse.
    Ohmura K; Kawamoto H; Fujimoto S; Ozaki S; Nakao K; Katsura Y
    J Immunol; 1999 Nov; 163(9):4788-95. PubMed ID: 10528178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
    Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
    J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The beta-galactosidase gene as a marker for hematopoietic reconstitution: individual cell analysis in a murine bone marrow transplantation model.
    Dolnikov A; Millington M; Beruter E; Shounan Y; Symonds G
    J Hematother Stem Cell Res; 2000 Oct; 9(5):659-72. PubMed ID: 11091490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine myeloid progenitor responses to GM-CSF and eosinophil precursor responses to IL-5 represent distinct targets for downmodulation by prostaglandin E(2).
    Gaspar Elsas MI; Joseph D; Lintomen L; Maximiano ES; Bodstein M; Xavier Elsas P; Vargaftig BB
    Br J Pharmacol; 2000 Jul; 130(6):1362-8. PubMed ID: 10903977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoid potential of primitive bone marrow progenitors evaluated in vitro.
    Wang H; Pierce LJ; Spangrude GJ
    Ann N Y Acad Sci; 2005 Jun; 1044():210-9. PubMed ID: 15958714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of IL-10 on murine CFU-pre-B formation.
    Fine JS; Macosko HD; Grace MJ; Narula SK
    Exp Hematol; 1994 Nov; 22(12):1188-96. PubMed ID: 7925782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mechanisms of the disordered regulation of hematopoiesis in the late periods after the administration of cytostatic preparations].
    Novitskiĭ VV; Zapuskalova OB; Bogdashin IV; Gol'dberg ED
    Patol Fiziol Eksp Ter; 1991; (3):12-4. PubMed ID: 1923603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of cancer stem cells and a strategy for their elimination.
    Dolgova EV; Alyamkina EA; Efremov YR; Nikolin VP; Popova NA; Tyrinova TV; Kozel AV; Minkevich AM; Andrushkevich OM; Zavyalov EL; Romaschenko AV; Bayborodin SI; Taranov OS; Omigov VV; Shevela EY; Stupak VV; Mishinov SV; Rogachev VA; Proskurina AS; Mayorov VI; Shurdov MA; Ostanin AA; Chernykh ER; Bogachev SS
    Cancer Biol Ther; 2014 Oct; 15(10):1378-94. PubMed ID: 25117082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leukocyte stimulation by DNA fragments shored up protamine in cyclophosphamide-induced leukopoiesis in mice].
    Dolgova EV; Rogachev VA; Nikolin VP; Popova NA; Likhacheva AS; Aliamkina EA; Sebeleva TE; Chernykh ER; Gel'fgat EL; Bogachev SS; Shudrov MA
    Vopr Onkol; 2009; 55(6):761-4. PubMed ID: 20210022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.
    Alyamkina EA; Nikolin VP; Popova NA; Dolgova EV; Proskurina AS; Orishchenko KE; Efremov YR; Chernykh ER; Ostanin AA; Sidorov SV; Ponomarenko DM; Zagrebelniy SN; Bogachev SS; Shurdov MA
    Genet Vaccines Ther; 2010 Nov; 8():7. PubMed ID: 21040569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of exogenous dna injection on leukopoietic repair and antitumor action of cyclophosphamide].
    Nikolin VP; Popova NA; Sebeleva TE; Strunkin DN; Rogachev VA; Semenov DV; Bogachev SS; Iakubov LA; Shurdov MA
    Vopr Onkol; 2006; 52(3):336-40. PubMed ID: 17191708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dimensional single cell mass cytometry analysis of the murine hematopoietic system reveals signatures induced by ageing and physiological pathogen challenges.
    Nikolaou C; Muehle K; Schlickeiser S; Japp AS; Matzmohr N; Kunkel D; Frentsch M; Thiel A
    Immun Ageing; 2021 Apr; 18(1):20. PubMed ID: 33879187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preclinical studies on the reaction of the blood-CFU-C-concentration to a single injection of cyclophosphamide (author's transl)].
    Müller-Nübling J; Fliedner TM
    Blut; 1979 Feb; 38(2):175-9. PubMed ID: 760877
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronometric Administration of Cyclophosphamide and a Double-Stranded DNA-Mix at Interstrand Crosslinks Repair Timing, Called "Karanahan" Therapy, Is Highly Efficient in a Weakly Immunogenic Lewis Carcinoma Model.
    Ruzanova V; Proskurina A; Efremov Y; Kirikovich S; Ritter G; Levites E; Dolgova E; Potter E; Babaeva O; Sidorov S; Taranov O; Ostanin A; Chernykh E; Bogachev S
    Pathol Oncol Res; 2022; 28():1610180. PubMed ID: 35693632
    [No Abstract]   [Full Text] [Related]  

  • 39. T-lymphoid progenitors - we know what they are, but know not what they may be.
    Bullinger L
    EMBO J; 2016 Nov; 35(22):2383-2385. PubMed ID: 27670761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts.
    Alyamkina EA; Nikolin VP; Popova NA; Minkevich AM; Kozel AV; Dolgova EV; Efremov YR; Bayborodin SI; Andrushkevich OM; Taranov OS; Omigov VV; Rogachev VA; Proskurina AS; Vereschagin EI; Kiseleva EV; Zhukova MV; Ostanin AA; Chernykh ER; Bogachev SS; Shurdov MA
    Cancer Cell Int; 2015; 15():32. PubMed ID: 25798073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.